Cargando…
Implication of IL-18 in chronic inflammation of severe refractory asthma
Autores principales: | Rovina, Nikoletta, Dima, Efrosini, Bakakos, Petros, Tseliou, Eleni, Kontogianni, Konstantina, Papiris, Spiridon, Koulouris, Nikolaos, Loukides, Stylianos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407177/ http://dx.doi.org/10.1186/2045-7022-5-S2-O10 |
Ejemplares similares
-
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015) -
Unraveling the Relationship of Asthma and COVID-19
por: Bakakos, Agamemnon, et al.
Publicado: (2021) -
Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021) -
Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016) -
C-Reactive Protein as a Predictor of Survival and Length of Hospital Stay in Community-Acquired Pneumonia
por: Travlos, Apostolos, et al.
Publicado: (2022)